Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

MLL rearranged acute lymphoblastic leukaemia presenting as a maxillary sinus mass with a discordant immunophenotypic profile from the bone marrow.

Wang YM, Mo JQ, Kuo DJ, Wong V.

BMJ Case Rep. 2019 Feb 15;12(2). pii: e227400. doi: 10.1136/bcr-2018-227400.

PMID:
30772833
2.

Immunohistochemical distinction of haematogones from B lymphoblastic leukaemia/lymphoma or B-cell acute lymphoblastic leukaemia (B-ALL) on bone marrow trephine biopsies: a study on 62 patients.

Al-Shieban S, Byrne E, Trivedi P, Morilla R, Matutes E, Naresh KN.

Br J Haematol. 2011 Aug;154(4):466-70. doi: 10.1111/j.1365-2141.2011.08760.x. Epub 2011 Jul 2.

PMID:
21722099
3.

Complex MLL rearrangement in non-infiltrated bone marrow in an infant with stage II precursor B-lymphoblastic lymphoma.

Ahlmann M, Meyer C, Marschalek R, Burkhardt B, Koehler G, Klapper W, Juergens H, Rossig C.

Eur J Haematol. 2014 Oct;93(4):349-53. doi: 10.1111/ejh.12314. Epub 2014 Apr 28.

PMID:
24635731
4.

Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy.

Gardner R, Wu D, Cherian S, Fang M, Hanafi LA, Finney O, Smithers H, Jensen MC, Riddell SR, Maloney DG, Turtle CJ.

Blood. 2016 May 19;127(20):2406-10. doi: 10.1182/blood-2015-08-665547. Epub 2016 Feb 23.

5.

Understanding the reconstitution of the B-cell compartment in bone marrow and blood after treatment for B-cell precursor acute lymphoblastic leukaemia.

Theunissen PMJ, van den Branden A, Van Der Sluijs-Gelling A, De Haas V, Beishuizen A, van Dongen JJM, Van Der Velden VHJ.

Br J Haematol. 2017 Jul;178(2):267-278. doi: 10.1111/bjh.14685. Epub 2017 May 25.

PMID:
28542787
6.

Therapy-related myeloid neoplasm in an 18-year-old boy with B-lymphoblastic leukemia.

Qing X, Panosyan E, Yue C, Ji P, Gotesman M, French S, Cai J.

Exp Mol Pathol. 2017 Dec;103(3):263-266. doi: 10.1016/j.yexmp.2017.11.007. Epub 2017 Nov 16.

PMID:
29155023
7.

Detailed immunophenotyping of B-cell precursors in regenerating bone marrow of acute lymphoblastic leukaemia patients: implications for minimal residual disease detection.

Theunissen PMJ, Sedek L, De Haas V, Szczepanski T, Van Der Sluijs A, Mejstrikova E, Nováková M, Kalina T, Lecrevisse Q, Orfao A, Lankester AC, van Dongen JJM, Van Der Velden VHJ; EuroFlow Consortium.

Br J Haematol. 2017 Jul;178(2):257-266. doi: 10.1111/bjh.14682. Epub 2017 Apr 17.

PMID:
28419441
8.

Discordance of MLL-rearranged (MLL-R) infant acute lymphoblastic leukemia in monozygotic twins with spontaneous clearance of preleukemic clone in unaffected twin.

Chuk MK, McIntyre E, Small D, Brown P.

Blood. 2009 Jun 25;113(26):6691-4. doi: 10.1182/blood-2009-01-202259. Epub 2009 May 1.

9.

Emergence of novel transient clonal chromosomal bone marrow changes in remission of acute lymphoblastic leukemia.

Andreasson P, Johansson B, Arheden K, Tedgård U, Ljung R, Heim S, Mitelmann F.

Leukemia. 1996 Feb;10(2):378-83. Review. No abstract available.

PMID:
8637252
10.

Prednisone induces immunophenotypic modulation of CD10 and CD34 in nonapoptotic B-cell precursor acute lymphoblastic leukemia cells.

Gaipa G, Basso G, Aliprandi S, Migliavacca M, Vallinoto C, Maglia O, Faini A, Veltroni M, Husak D, Schumich A, Ratei R, Biondi A, Dworzak MN; I-BFM-ALL-FCM-MRD-Study Group.

Cytometry B Clin Cytom. 2008 May;74(3):150-5. doi: 10.1002/cyto.b.20408.

11.

Cutaneous precursor B-cell lymphoblastic lymphoma in 2 adult patients: clinicopathologic and molecular cytogenetic studies with a review of the literature.

Shafer D, Wu H, Al-Saleem T, Reddy K, Borghaei H, Lessin S, Smith M.

Arch Dermatol. 2008 Sep;144(9):1155-62. doi: 10.1001/archderm.144.9.1155. Review.

PMID:
18794461
12.

MLL-rearranged mixed phenotype acute leukemia masquerading as B-cell ALL.

Yang W, Tran P, Khan Z, Rezk S, O'Brien S.

Leuk Lymphoma. 2017 Jun;58(6):1498-1501. doi: 10.1080/10428194.2016.1246728. Epub 2016 Oct 24. No abstract available.

PMID:
27774846
13.
14.

Lymphoblastic lymphoma.

Cortelazzo S, Ponzoni M, Ferreri AJ, Hoelzer D.

Crit Rev Oncol Hematol. 2011 Sep;79(3):330-43. doi: 10.1016/j.critrevonc.2010.12.003. Epub 2011 Jan 26. Review.

PMID:
21273093
15.

Mixed lineage leukemia-rearranged childhood pro-B and CD10-negative pre-B acute lymphoblastic leukemia constitute a distinct clinical entity.

Attarbaschi A, Mann G, König M, Steiner M, Strehl S, Schreiberhuber A, Schneider B, Meyer C, Marschalek R, Borkhardt A, Pickl WF, Lion T, Gadner H, Haas OA, Dworzak MN.

Clin Cancer Res. 2006 May 15;12(10):2988-94.

16.

H3K79 methylation profiles define murine and human MLL-AF4 leukemias.

Krivtsov AV, Feng Z, Lemieux ME, Faber J, Vempati S, Sinha AU, Xia X, Jesneck J, Bracken AP, Silverman LB, Kutok JL, Kung AL, Armstrong SA.

Cancer Cell. 2008 Nov 4;14(5):355-68. doi: 10.1016/j.ccr.2008.10.001.

17.

Two consecutive immunophenotypic switches in a child with MLL-rearranged acute lymphoblastic leukemia.

Germano G, Pigazzi M, del Giudice L, Campo Dell'Orto M, Spinelli M, Zangrando A, Paolucci P, Ladogana S, Basso G.

Haematologica. 2006 May;91(5 Suppl):ECR09.

18.

Lymphoblastic leukemia with mature B-cell phenotype in infancy.

Frater JL, Batanian JR, O'Connor DM, Grosso LE.

J Pediatr Hematol Oncol. 2004 Oct;26(10):672-7. Review.

PMID:
15454841
19.

Precursor B lymphoblastic leukemia 32 months after local therapy for a primary extramedullary myeloid cell tumor.

Szinnai G, Cogliatti SB, Avoledo P, Dirnhofer S, Schmid U, Kühne T.

Pediatr Blood Cancer. 2007 Dec;49(7):1039-46.

PMID:
16572408
20.

Acute myelofibrosis terminating in acute lymphoblastic leukemia: case report and review of the literature.

Dunphy CH, Kitchen S, Saravia O, Velasquez WS.

Am J Hematol. 1996 Jan;51(1):85-9. Review.

Supplemental Content

Support Center